CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ)

$1.17 0.03 (2.6316%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 76

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ) News Sources

CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia

02-10-2025

yahoo.com

CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets

14-10-2025

yahoo.com

CytoMed Therapeutics’ Chairman Increases Effective Holdings to 21.95%

22-10-2025

yahoo.com

CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy

06-11-2025

yahoo.com

CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India

18-11-2025

yahoo.com

CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia

08-12-2025

yahoo.com

CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital

13-01-2026

yahoo.com

CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress

28-01-2026

yahoo.com

Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress

29-01-2026

yahoo.com

CytoMed Therapeutics And 2 More Penny Stocks With Promising Prospects

06-02-2026

yahoo.com

CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ) Sentiment Trend

0 25 50 75 100 76 79 80 79 77 74 76 78 48 90 02-10-2025 14-10-2025 22-10-2025 06-11-2025 18-11-2025 08-12-2025 13-01-2026 28-01-2026 29-01-2026 06-02-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ) FAQs

toggle

What is the current price of CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ)?

The current price of CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ) is $1.17.


toggle

CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ) absolute price change since previous trading day?

The absolute price change of CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ) since the previous trading day is $0.03.


toggle

CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ) percentage price change since previous trading day?

The percentage price change of CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ) since the previous trading day is 2.6316%.


toggle

What is the most recent average sentiment score for CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ)?

The most recent average sentiment score for CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ) is 76 out of 100.


toggle

What is the most recent average sentiment for CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ)?

The most recent sentiment for CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ) is .


SEC-8K** Filing Available For CYTOMED THERAPEUTICS LTD (GDTC:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.